Convert Pharmaceuticals is a clinical-stage biotech company, developing a proprietary pipeline of biomarker-enabled hypoxia-activated prodrugs to treat resistant solid tumors.
| Website | http://www.convertpharma.com |
| Revenue | $5.5 million |
| Employees | 7 (2 on RocketReach) |
| Founded | 2018 |
| Address | 6 Quai Banning, Liege, Wallonia 4000, BE |
| Phone | +32 2 880 67 30 |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Biotech, Drug Development, Drug Discovery, Clinical Stage, Cancer Treatment, Pharmaceutical Research, Cancer Research, Oncology, Solid Tumors, Therapeutics, Clinical Trials, Targeted Therapy, Cancer Drugs, Precision Medicine, Pipeline |
| Competitors | Teva Pharmaceuticals, Mylan Belgium, Amgen, Gilead Sciences, Roche, Novartis, Bristol Myers Squibb, Pfizer, Johnson & Johnson, Lilly India +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Convert Pharmaceuticals employee's phone or email?
Convert Pharmaceuticals Questions
The Convert Pharmaceuticals annual revenue was $5.5 million in 2026.
Philippe Lambin is the Founder and part-time CEO of Convert Pharmaceuticals.
2 people are employed at Convert Pharmaceuticals.
Convert Pharmaceuticals is based in Liege, Wallonia.
The NAICS codes for Convert Pharmaceuticals are [3254, 325, 32541, 32].
The SIC codes for Convert Pharmaceuticals are [283, 28].
Top Convert Pharmaceuticals Employees
Related Companies
